Product Information
FLUTICASONE ELLIPTA 200 MCG INH is a generic product labeled by Prasco Laboratories, priced at $5.7140 per EA under NDC 66993016897. Its NADAC has been published 46 times since Nov 19, 2025.
FDA first approved this application on Aug 20, 2014.
Strength
200 ug/1
Manufacturer
Prasco LaboratoriesNDC
66993016897
Classification
Generic
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
FLUTICASONE FUROATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA205625FDA Approved
8/20/2014
On Market Since
7/21/2025
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE ELLIPTA 200 MCG INH has been published 46 times since Nov 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.7140 per EA |
|---|---|
| All-time high | $5.8190 (Jan 14, 2026) |
| All-time low | $5.6699 (Jun 17, 2026) |
| 52-week high | $5.8190 |
| 52-week low | $5.6699 |
| Median price | $5.7246 |
| Average price | $5.7416 |
| Largest weekly change | -0.8% (May 20, 2026) |
| Weeks tracked | 46 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluticasone furoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUTICASONE ELLIPTA 200 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE ELLIPTA 200 MCG INH, manufactured by Prasco Laboratories, is $5.7140 per EA (NDC 66993016897), effective Sep 30, 2026.
How has the price of FLUTICASONE ELLIPTA 200 MCG INH changed over time?
Over the history we have for it, the NADAC for FLUTICASONE ELLIPTA 200 MCG INH has held within roughly two percent of its current level. It has been tracked across 46 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for FLUTICASONE ELLIPTA 200 MCG INH?
Since Nov 19, 2025, the NADAC for FLUTICASONE ELLIPTA 200 MCG INH has ranged from a low of $5.6699 (Jun 17, 2026) to a high of $5.8190 (Jan 14, 2026), with a median of $5.7246 per EA.
Are there cheaper alternatives to FLUTICASONE ELLIPTA 200 MCG INH?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLUTICASONE ELLIPTA 200 MCG INH in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUTICASONE ELLIPTA 200 MCG INH?
FLUTICASONE ELLIPTA 200 MCG INH (NDC 66993016897) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.